After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy ...

Bankrupt genetic testing company 23andMe is looking to sell its assets — most notably its customers' DNA data — for more than ...

Regeneron is willing to make a new bid for 23andMe's assets, but wants a $10 million breakup fee if Wojcicki’s bid is ...

The founder of 23andMe, Anne Wojcicki, has asked a judge to reopen an auction for the genetic testing company, saying she has ...

Kymera's KT-621 achieved rapid, deep STAT6 degradation and showed a strong safety profile in Phase 1, with the next trials ...

In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...

Regeneron Pharmaceuticals said on Monday its experimental weight-loss drug combination helped preserve muscle mass in a ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after ...

Regeneron Pharmaceuticals (NASDAQ:REGN) operates within the biotechnology sector and is listed on Biggest Companies on Nasdaq ...

Mary Kay Inc., a global advocate for furthering young women’s education and encouraging youth to follow their STEM dreams, ...